Tagged with Allist

China Pharma News: US Bill Slapping Chinese Biotechs Advances; Innovent Shows Shining Phase III Results for Obesity Candidate

China China Pharma News: US Bill Slapping Chinese Biotechs Advances; Innovent Shows Shining Phase III Results for Obesity Candidate

China A roundup of some of the biggest China pharma industry stories, including the progress of the US Biosecure Act targeting Chinese biotechs; Innovent’s obesity and type 2 diabetes contender’s positive phase III trial results; the strategic partnership between Sino Biological and BioGeometry; CSL’s sale of its China-based plasma collection operations…